Profusa (PFSA) Restructuring Costs (2025)
Profusa (PFSA) posted quarterly Restructuring Costs of $15.0 million for Q3 2025.
Profusa (PFSA) Restructuring Costs (2025) Analysis & Trends
Profusa's Restructuring Costs history runs 1 years deep, the most recent figure standing at $15.0 million for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Profusa | 122,208.31 | -252,791.69 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15.00 Mn |